Standout Papers

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastat... 2008 2026 2014 2020 2.2k
  1. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2008)
    Leonard B. Saltz, Stephen Clarke et al. Journal of Clinical Oncology
  2. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial (2008)
    Bernard Nordlinger, Halfdan Sørbye et al. The Lancet
  3. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial (2013)
    Bernard Nordlinger, Halfdan Sørbye et al. The Lancet Oncology
  4. EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer (2008)
    Alberto Sobrero, Joan Maurel et al. Journal of Clinical Oncology
  5. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer (2008)
    Jim Cassidy, Stephen Clarke et al. Journal of Clinical Oncology
  6. Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer (2009)
    David Cunningham, Ian Chau et al. Journal of Clinical Oncology
  7. nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial (2015)
    David Goldstein, Robert H. El-Maraghi et al. JNCI Journal of the National Cancer Institute
  8. Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer (2009)
    Eric Van Cutsem, Walter L. Vervenne et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 2 from Science/Nature 118 standout
Sub-graph 1 of 14

Citing Papers

Colorectal cancer
2024 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
40 intermediate papers

Works of Werner Scheithauer being referenced

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
2015 Standout
Updated survival from a randomized phase III trial (MPACT) of nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients (pts) with metastatic adenocarcinoma of the pancreas.
2014
and 30 more

Author Peers

Author Last Decade Papers Cites
Werner Scheithauer 14209 5302 2288 4496 346 17.8k
Christophe Louvet 14592 5964 2427 3574 278 17.4k
Steven R. Alberts 12210 5103 2286 3263 308 16.8k
Valérie Boige 9238 6005 1918 3856 282 17.2k
Ian Chau 12763 6982 2318 3130 463 18.2k
Cathy Eng 10553 3748 1793 4176 402 15.7k
Alan P. Venook 9629 3744 2914 5085 361 17.1k
Aimery de Gramont 19720 6646 2362 4641 332 24.4k
Chris Verslype 7097 3724 2077 5995 332 15.0k
Axel Grothey 13763 4716 2440 3257 329 18.0k
Bernard Nordlinger 14597 5452 1764 9245 262 21.0k

All Works

Loading papers...

Rankless by CCL
2026